The company, which is being purchased by Danaher, did not report its earnings for the fourth quarter, but based on what it had previously reported for the first three quarters, revenues for the final quarter of 2010 were $986.5 million.
At the Association for Mass Spectrometry's Applications to the Clinical Lab meeting this week, proteomics researchers highlighted the need for higher-throughput assays, with several introducing automated SISCAPA workflows employing instruments from vendors including Agilent Technologies and Thermo Fisher Scientific.
The action is an amendment to a lawsuit in which plaintiffs argued that the company, its board, and certain of its officers breached their fiduciary duty in connection to the company's trouble with its Accutn1 troponin test last year.
The announcement follows developments last year in which next-gen sequencing uncovered fragments of a porcine circovirus within a rotavirus vaccine, prompting the US Food and Drug Administration to consider the use of sequencing as a quality-control measure for vaccines and biologics.
Transgene plans to use the tests from Ventana and Beckman Coulter to analyze which subpopulations of patients with advanced NSCLC will likely respond best to the MVA-MUC1-IL2 immunotherapeutic in combination with first-line therapy.